Search

Novozymes A-S (Class B)

Închisă

0

Rezumat

Modificarea prețului

24h

Curent

Minim

Maxim

Indicatori cheie

By Trading Economics

Venit

-15M

123M

Vânzări

-505M

7.4B

P/E

Medie Sector

41.326

32.651

EPS

3.36

Randament dividend

0.22

Marjă de profit

1.65

Angajați

10,933

EBITDA

-440M

2B

Recomandări

By TipRanks

Recomandări

Neutru

Prognoză pe 12 luni

+22.59% upside

Dividende

By Dow Jones

Randament dividend

Medie Sector

0.22%

2.88%

Următoarele câștiguri

5 mai 2026

Statistici piață

By TradingEconomics

Capitalizare de piață

-249M

180B

Deschiderea anterioară

0

Închiderea anterioară

0

Novozymes A-S (Class B) Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

6 apr. 2026, 23:17 UTC

Câștiguri

Samsung Forecasts Record First-Quarter Operating Profit

6 apr. 2026, 23:00 UTC

Acțiuni populare

Stocks to Watch: Health Insurers, Mawson, Owlet

6 apr. 2026, 22:13 UTC

Principalele dinamici ale pieței

Health Insurance Shares Gain on 2.48% Medicare Rate Bump

6 apr. 2026, 21:46 UTC

Achiziții, Fuziuni, Preluări

BP 'Optimizes Portfolio' and Sells 13 Thorntons Stores to Giant Oil -- OPIS

6 apr. 2026, 17:09 UTC

Principalele dinamici ale pieței

Viridian Shares Fall After Competing Amgen Eye Drug Performs Well

6 apr. 2026, 16:56 UTC

Evenimente importante

U.S. Released 1.5 Million Bbls of Crude From SPR Last Week, DOE Data Show -- OPIS

6 apr. 2026, 14:47 UTC

Principalele dinamici ale pieței

Stereotaxis Shares Rise on FDA Clearance for Synchrony

7 apr. 2026, 00:00 UTC

Evenimente importante

Ukraine's Lesson for Trump: Military Dominance Opens Waterways -- WSJ

6 apr. 2026, 23:58 UTC

Market Talk
Evenimente importante

Iran War Will Keep Oil Prices High Through 2Q, Says Westpac -- Market Talk

6 apr. 2026, 23:50 UTC

Market Talk

Nikkei May Rise on Hopes for Iran Cease-Fire -- Market Talk

6 apr. 2026, 23:36 UTC

Market Talk

Gold Edges Higher as Investors Focus on U.S.-Iran Conflict -- Market Talk

6 apr. 2026, 23:15 UTC

Market Talk

RBA Won't Raise Rates as Australia's Economy Softens Fast -- Market Talk

6 apr. 2026, 22:52 UTC

Market Talk

Global Equities Roundup: Market Talk

6 apr. 2026, 22:52 UTC

Market Talk

Pro Medicus Unlikely to Complete New Buyback in Full -- Market Talk

6 apr. 2026, 22:14 UTC

Market Talk

Correction to Live Cattle Futures Article

6 apr. 2026, 20:56 UTC

Market Talk

Mexican Private Consumption Fell in January -- Market Talk

6 apr. 2026, 20:50 UTC

Market Talk

Energy & Utilities Roundup: Market Talk

6 apr. 2026, 20:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

6 apr. 2026, 19:58 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

6 apr. 2026, 19:58 UTC

Market Talk

Live Cattle Futures Hit Record High, Hogs Edge Up -- Market Talk

6 apr. 2026, 19:11 UTC

Market Talk

U.S. Natural Gas Edges Up in Rangebound Trade -- Market Talk

6 apr. 2026, 19:06 UTC

Market Talk

Treasury Yields Decline as a Belligerent Trump Talks to Reporters -- Market Talk

6 apr. 2026, 19:03 UTC

Market Talk

Global Energy Roundup: Market Talk

6 apr. 2026, 19:03 UTC

Market Talk

Crude Futures Edge Up As Trump's Iran Deadline Nears -- Market Talk

6 apr. 2026, 18:36 UTC

Achiziții, Fuziuni, Preluări

Soleno Stock Soars 32% on $2.9 Billion Neurocrine Buyout. Why Its Hunger Drug Is a Different Weight-Loss Play. -- Barrons.com

6 apr. 2026, 17:59 UTC

Market Talk
Evenimente importante

Travel Booking Companies Facing More Demand Uncertainty Than Expected -- Market Talk

6 apr. 2026, 17:13 UTC

Achiziții, Fuziuni, Preluări

Soleno Stock Soars 32% on $2.9 Billion Neurocrine Buyout. Why Its Hunger Drug Is a Different Weight-Loss Play. -- Barrons.com

6 apr. 2026, 16:33 UTC

Market Talk

Oil Futures Steady as Market Awaits Trump -- Market Talk

6 apr. 2026, 16:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

6 apr. 2026, 14:59 UTC

Câștiguri

Strategy Records a $14.5 Billion Unrealized Loss in First Quarter -- WSJ

Novozymes A-S (Class B) Așteptări

Obiectiv de preț

By TipRanks

22.59% sus

Prognoză pe 12 luni

Medie 400 DKK  22.59%

Maxim 520 DKK

Minim 300 DKK

În baza a 3 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruNovozymes A-S (Class B) - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Neutru

3 ratings

1

Cumpărare

1

Păstrare

1

Vânzare

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Novozymes A-S (Class B)

Novonesis A/S produces and sells industrial enzymes, microorganisms, and probiotics in Denmark, rest of Europe, North America, Asia Pacific, the Middle East, Africa, Latin America, and internationally. The company offers protein solutions for the food and beverage industry. It also offers industrial hygiene, drain openers, hard surface, medical cleaning, septic tanks, ware washing, and professional laundry services. In addition, the company provides dishwashing, softener, microbial and medical cleaning services. Further, it provides corn, cotton, forages, peanuts, pulses, soybeans, wheat, small grains, bioyield, and biocontrol solutions; warm water species, recirculating aquaculture system; animal health and nutrition solutions; fiber modification, bleach boosting, deposit control, and starch modification solutions. Additionally, the company provides carbon capture, leather and textiles solutions; enzyme solutions, including corn and wheat separation, liquefaction, saccharification, filtration, isomerization, maltose, and specialties solutions; warm water species and recirculating aquaculture system solutions; human health solutions, comprising brain, oral, protective and immune, and gastrointestinal health solutions; ethanol, biodiesel, renewable diesel, education, wastewater, and sewage sludge, and renewable diesel solutions; agriculture and industry, biogas food waste, food waste, biocatalysis, cell culture, diagnostics, enzyme, and biogas solutions. Furthermore, it provides lipases, proteases, oxidoreductases, and carbohydrases. Novonesis A/S was founded in 1925 and is based in Bagsvaerd, Denmark.
help-icon Live chat